TR200103039T2 - Pharmaceutical composition in a unit form containing acetylsalicylic acid and clopidogrel hydrogenosulfate. - Google Patents
Pharmaceutical composition in a unit form containing acetylsalicylic acid and clopidogrel hydrogenosulfate.Info
- Publication number
- TR200103039T2 TR200103039T2 TR2001/03039T TR200103039T TR200103039T2 TR 200103039 T2 TR200103039 T2 TR 200103039T2 TR 2001/03039 T TR2001/03039 T TR 2001/03039T TR 200103039 T TR200103039 T TR 200103039T TR 200103039 T2 TR200103039 T2 TR 200103039T2
- Authority
- TR
- Turkey
- Prior art keywords
- hydrogenosulfate
- pharmaceutical composition
- clopidogrel
- unit form
- acetylsalicylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut bulus; asetilsalisik asit ve klopidogrel hidrojenosülfattan mütesekkil platelet anti-agregat aktiviteye sahip aktif özlerin bir kombinasyonunu ihtiva eden bir birim galenik formda saglanmis olan farmasötik bir kompozisyon ile ilgilidir.Current invention; It relates to a pharmaceutical composition provided in a unit galenic form comprising a combination of acetylsalicic acid and active extracts having clotelid anti-aggregate activity of platelet anti-aggregate hydrogenosulfate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905497A FR2792836B3 (en) | 1999-04-30 | 1999-04-30 | PHARMACEUTICAL COMPOSITION IN UNIT FORM CONTAINING ASPIRIN AND CLOPIDOGREL HYDROGENOSULFATE |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200103039T2 true TR200103039T2 (en) | 2002-01-21 |
Family
ID=9545071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03039T TR200103039T2 (en) | 1999-04-30 | 2000-04-25 | Pharmaceutical composition in a unit form containing acetylsalicylic acid and clopidogrel hydrogenosulfate. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1178809A1 (en) |
JP (1) | JP2002543137A (en) |
KR (1) | KR20020005735A (en) |
CN (1) | CN1359294A (en) |
AR (1) | AR023789A1 (en) |
AU (1) | AU4303600A (en) |
BR (1) | BR0010194A (en) |
CA (1) | CA2371231A1 (en) |
CZ (1) | CZ20013887A3 (en) |
EA (1) | EA200100959A1 (en) |
EE (1) | EE200100559A (en) |
FR (1) | FR2792836B3 (en) |
HK (1) | HK1041823A1 (en) |
HU (1) | HUP0202329A2 (en) |
IL (1) | IL145648A0 (en) |
IS (1) | IS6084A (en) |
MX (1) | MXPA01011071A (en) |
NO (1) | NO20015295L (en) |
NZ (1) | NZ514248A (en) |
PL (1) | PL351923A1 (en) |
SK (1) | SK15542001A3 (en) |
TR (1) | TR200103039T2 (en) |
UY (1) | UY26131A1 (en) |
WO (1) | WO2000066130A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100341506C (en) | 2000-12-25 | 2007-10-10 | 三共株式会社 | Medical compositions containing aspirin |
US6767913B2 (en) | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
US6800759B2 (en) | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
IL166593A0 (en) | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel | |
JP4917255B2 (en) * | 2003-10-16 | 2012-04-18 | 第一三共ヘルスケア株式会社 | Oral composition containing salicylic acids |
WO2005070464A2 (en) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of clopidogrel bisulphate |
BRPI0611626A2 (en) * | 2005-06-13 | 2010-09-21 | Elan Pharma Int Ltd | Combination Formulations of Clopidogrel and Aspirin Nanoparticles |
KR20070009851A (en) * | 2005-07-14 | 2007-01-19 | 씨제이 주식회사 | Pharmaceutical compositions containing clopidogrel bisulfate |
CN101253179B (en) * | 2005-09-21 | 2010-12-29 | 株式会社钟根堂 | Novel resinate complex of S-clopidogrel and production method thereof |
KR20070044323A (en) * | 2005-10-24 | 2007-04-27 | 에스케이케미칼주식회사 | Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate |
JP2009532462A (en) * | 2006-04-05 | 2009-09-10 | カディラ・ヘルスケア・リミテッド | Modified release clopidogrel formulation |
EP1900358A1 (en) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
CN101951896B (en) * | 2008-02-22 | 2012-11-28 | 韩兀生物制药株式会社 | Composite preparation |
CN101695496A (en) * | 2009-10-15 | 2010-04-21 | 苏春华 | Medicinal composition containing triflusal and clopidogrel |
JP2013032289A (en) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | Wax stable formulation |
RU2484820C2 (en) * | 2011-02-24 | 2013-06-20 | Общество с ограниченной ответственностью "Озон" | Combined medicine as thrombocyte aggregation inhibitor |
KR101675501B1 (en) * | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | Combination of Clopidogrel and Aspirin |
CN102406938A (en) * | 2011-11-29 | 2012-04-11 | 北京阜康仁生物制药科技有限公司 | Medicine composition for resisting thrombosis |
JP6004524B2 (en) * | 2012-07-11 | 2016-10-12 | 大原薬品工業株式会社 | Method for producing clopidogrel sulfate-containing tablets |
JP5905165B2 (en) * | 2013-08-02 | 2016-04-20 | サノフイ | Pharmaceutical tablets containing acetylsalicylic acid and clopidogrel |
CN104434932B (en) * | 2014-12-18 | 2017-05-24 | 成都苑东生物制药股份有限公司 | Pharmaceutical composition of clopidogrel hydrogen sulfate and acetylsalicylic acid tablet and preparation method thereof |
WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
CN115737578A (en) * | 2022-11-23 | 2023-03-07 | 石家庄四药有限公司 | Clopidogrel hydrogen sulfate and aspirin compound tablet and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (en) | 1987-02-17 | 1992-01-24 | Sanofi Sa | ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
US5576328A (en) * | 1994-01-31 | 1996-11-19 | Elf Sanofi | Method for the secondary prevention of ischemic events |
FR2744918B1 (en) | 1996-02-19 | 1998-05-07 | Sanofi Sa | NEW COMBINATIONS OF ACTIVE INGREDIENTS CONTAINING THIENO (3,2-C) PYRIDINE DERIVATIVE AND AN ANTITHROMBOTIC |
FR2779726B1 (en) | 1998-06-15 | 2001-05-18 | Sanofi Sa | POLYMORPHIC FORM OF CLOPIDOGREL HYDROGENOSULFATE |
-
1999
- 1999-04-30 FR FR9905497A patent/FR2792836B3/en not_active Expired - Fee Related
-
2000
- 2000-04-25 CA CA002371231A patent/CA2371231A1/en not_active Abandoned
- 2000-04-25 EP EP00922737A patent/EP1178809A1/en not_active Withdrawn
- 2000-04-25 AU AU43036/00A patent/AU4303600A/en not_active Abandoned
- 2000-04-25 TR TR2001/03039T patent/TR200103039T2/en unknown
- 2000-04-25 IL IL14564800A patent/IL145648A0/en unknown
- 2000-04-25 EE EEP200100559A patent/EE200100559A/en unknown
- 2000-04-25 WO PCT/FR2000/001086 patent/WO2000066130A1/en not_active Application Discontinuation
- 2000-04-25 CZ CZ20013887A patent/CZ20013887A3/en unknown
- 2000-04-25 CN CN00807001A patent/CN1359294A/en active Pending
- 2000-04-25 KR KR1020017013830A patent/KR20020005735A/en not_active Application Discontinuation
- 2000-04-25 HU HU0202329A patent/HUP0202329A2/en unknown
- 2000-04-25 BR BR0010194-0A patent/BR0010194A/en not_active Application Discontinuation
- 2000-04-25 NZ NZ514248A patent/NZ514248A/en unknown
- 2000-04-25 EA EA200100959A patent/EA200100959A1/en unknown
- 2000-04-25 JP JP2000615014A patent/JP2002543137A/en not_active Withdrawn
- 2000-04-25 SK SK1554-2001A patent/SK15542001A3/en unknown
- 2000-04-25 MX MXPA01011071A patent/MXPA01011071A/en unknown
- 2000-04-25 PL PL00351923A patent/PL351923A1/en not_active Application Discontinuation
- 2000-04-28 UY UY26131A patent/UY26131A1/en not_active Application Discontinuation
- 2000-04-28 AR ARP000102020A patent/AR023789A1/en unknown
-
2001
- 2001-09-25 IS IS6084A patent/IS6084A/en unknown
- 2001-10-29 NO NO20015295A patent/NO20015295L/en not_active Application Discontinuation
-
2002
- 2002-05-14 HK HK02103639.9A patent/HK1041823A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002543137A (en) | 2002-12-17 |
SK15542001A3 (en) | 2002-02-05 |
HK1041823A1 (en) | 2002-07-26 |
WO2000066130A1 (en) | 2000-11-09 |
AU4303600A (en) | 2000-11-17 |
CZ20013887A3 (en) | 2002-02-13 |
UY26131A1 (en) | 2000-12-29 |
BR0010194A (en) | 2002-02-13 |
NZ514248A (en) | 2003-06-30 |
MXPA01011071A (en) | 2002-07-22 |
HUP0202329A2 (en) | 2002-10-28 |
EE200100559A (en) | 2003-02-17 |
FR2792836B3 (en) | 2001-07-27 |
CN1359294A (en) | 2002-07-17 |
IL145648A0 (en) | 2002-06-30 |
CA2371231A1 (en) | 2000-11-09 |
FR2792836A1 (en) | 2000-11-03 |
NO20015295L (en) | 2001-12-21 |
EA200100959A1 (en) | 2002-06-27 |
KR20020005735A (en) | 2002-01-17 |
EP1178809A1 (en) | 2002-02-13 |
NO20015295D0 (en) | 2001-10-29 |
IS6084A (en) | 2001-09-25 |
AR023789A1 (en) | 2002-09-04 |
PL351923A1 (en) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200103039T2 (en) | Pharmaceutical composition in a unit form containing acetylsalicylic acid and clopidogrel hydrogenosulfate. | |
ES2176684T3 (en) | NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC. | |
TR200302105T4 (en) | Eye formulations containing cyclosporine, hyaluronic acid and polysorbate. | |
BR9607128A (en) | Topical emulsion perfected to load ascorbic acid and water-soluble active ingredients and getatin soft capsule | |
ES2037866T3 (en) | A DEODORATING COMPOSITION IN THE FORM OF GEL. | |
WO1999020228A3 (en) | Disinfecting agent | |
DE60036861D1 (en) | Encapsulation of biologically active complexes in liposomes | |
IL152339A0 (en) | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | |
BR9804802A (en) | Composition of sustained release of drugs encapsulated in hyaluronic acid micropoarticles | |
NO20031623D0 (en) | Liposomal formulation of mitoxantrone | |
AU8799101A (en) | Sharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases | |
TR200200982T2 (en) | Pharmaceutical composition compositions. | |
BR0113751A (en) | Cosmetic and pharmaceutical compositions and their uses | |
PT1128812E (en) | NANOEMULATION OF 5-AMINOLEVULINIC ACID | |
TR200100361T2 (en) | New oral formulation | |
TR200103427T2 (en) | Propanoic acid derivatives that inhibit the binding of integrins to their receptors. | |
IS5582A (en) | Meta-azahringaminobenzoic acid compounds and their derivatives prove to be antagonists of integrin. | |
DE60004797D1 (en) | MEDICINAL PRODUCTS WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES CONTAINING ISOQUERCETINE AND ASCORBIC ACID | |
DE59909341D1 (en) | RETARD FORMULATIONS OF PLANT PROTECTION ACTIVE INGREDIENTS | |
CO4960657A1 (en) | PHARMACEUTICAL COMPOSITION | |
HRP20010764B1 (en) | Prucalopride oral solution | |
RU95113437A (en) | Trans-2-dimethylamino-1-phenyl-3-cyclohexene-trans-1- carboxylic acid ±-ethyl ester as primary orthophosphate and solid pharmaceutical composition having pain-killing activity | |
EP1066816A4 (en) | Agents promoting laminin production in skin cells | |
NO20013015L (en) | Liposomine inflammatory acid - new transdermal anti-inflammatory drug | |
DE60302951D1 (en) | Pyroglutamic acid salt of amlodipine |